Finance

Lists
PER:ASX
Percheron Therapeutics Ltd
0,0030 AUD
0,00%
(0,00) 1D
4-ноя., 16:10:07 GMT+11  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for PER...
Open
0,00 AUD
High
0,00 AUD
Low
0,00 AUD
Mkt. cap
2,73 млн
Avg. vol.
3,60 млн
Volume
3,15 млн
52-wk high
0,01 AUD
52-wk low
0,00 AUD
EPS
-0,00 AUD
Shares outstanding
1,98 млд
No. of employees
8
Open
0,00 AUD
High
0,00 AUD
Low
0,00 AUD
Mkt. cap
2,73 млн
Avg. vol.
3,60 млн
Volume
3,15 млн
52-wk high
0,01 AUD
52-wk low
0,00 AUD
EPS
-0,00 AUD
Shares outstanding
1,98 млд
No. of employees
8
News stories
From web sources and news partners
ABC News - Breaking News, Latest News and Videos
ABC News - Breaking News, Latest News and Videos
·
3 саат мурун
Dow surges 1,000 points as Democrats take control of Congress
About Percheron Therapeutics Ltd
CEOJames Garner
Employees8
Founded2000
HeadquartersТоорак, Виктория, Австралия
SectorPharmaceutical industry
Industry-
Previous reportsAll values in AUD
Loading Previous Earnings...
Revenue
Net income
All values in AUD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
44,20 миң
44,20 миң
377,60 миң
377,60 миң
Cost of goods sold
58,63 миң
58,63 миң
31,06 миң
31,06 миң
Cost of revenue
58,63 миң
58,63 миң
31,06 миң
31,06 миң
Research and development expenses
671,18 миң
671,18 миң
372,60 миң
372,60 миң
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
732,56 миң
732,56 миң
657,51 миң
657,51 миң
Operating expense
1,53 млн
1,53 млн
1,19 млн
1,19 млн
Total operating expenses
1,59 млн
1,59 млн
1,22 млн
1,22 млн
Operating income
-1,55 млн
-1,55 млн
-840,64 миң
-840,64 миң
Other non operating income
-
-
-
-
EBT including unusual items
-1,55 млн
-1,55 млн
-843,02 миң
-843,02 миң
EBT excluding unusual items
-1,55 млн
-1,55 млн
-843,02 миң
-843,02 миң
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1,55 млн
-1,55 млн
-843,02 миң
-843,02 миң
Net profit margin
-3 512,84%
-3 512,84%
-223,26%
-223,26%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-5,29 миң
-5,29 миң
-2,38 миң
-2,38 миң
Net interest expenses
-5,29 миң
-5,29 миң
-2,38 миң
-2,38 миң
Depreciation and amortization charges
9,56 миң
9,56 миң
100,22 миң
100,22 миң
EBITDA
-1,54 млн
-1,54 млн
-740,42 миң
-740,42 миң
Gain or loss from assets sale
-
-
20,00
20,00
Upcoming events
AI content may include mistakes. Learn more
Google колдонмолору